Advanced Colloidal Particle Tech: Multisector Innovation

Publication ID: 24-11856948_0002_PTD
Published: October 26, 2025
Category:New Applications & Use Cases

Legal Citation

pr1or.art Inc., “Advanced Colloidal Particle Tech: Multisector Innovation,” Published Technical Disclosure No. 24-11856948_0002_PTD, Published October 26, 2025, available at https://archive.pr1or.art/24-11856948_0002_PTD
This technical disclosure describes improvements that would be readily apparent to a Person Having Ordinary Skill In The Art (PHOSITA) when considered in combination with the foundational architecture disclosed in U.S. Patent No. 11,856,948.

Background and Problem Solved

The original patent disclosed a composite colloidal particle formulation with advanced functionality for general applications. However, the patent did not explore the formulation's potential in diverse industries. This invention addresses the limitation by applying the core technology to new fields, providing innovative solutions for specific problems.

Novelty and Inventive Step

The new claims introduce novel applications and use cases for the original colloidal particle formulation, demonstrating a non-obvious expansion of the technology's capabilities. The inventive step lies in the recognition of the formulation's potential in these new fields and the development of specific designs and methods to address the unique challenges in each application.

Alternative Embodiments and Variations

Alternative embodiments of the invention may include modifications to the bioadhesive polyelectrolyte solution, the engineered biodegradable particle core, or the method of production to further optimize the formulation's performance in specific applications. Variations may also include the use of different active ingredients, particle sizes, or surface modifications to tailor the formulation to specific needs.

Potential Commercial Applications and Market

The invention has significant commercial potential in the cosmetic, pharmaceutical, and environmental industries. The targeted delivery of active ingredients in cosmetic treatments, the efficient treatment of acne, and the controlled administration of oral vaccines can revolutionize these markets. Additionally, the formulation's ability to detect and quantify pollutants in water samples and treat respiratory diseases can address pressing environmental and health concerns.

CPC Classifications

SectionClassGroup
A A01 A01N25/22
A A01 A01N25/04
A A01 A01N25/10
A A01 A01N59/20

Field of Art

Colloidal particle formulation technologies, specifically focused on biodegradable particle systems with polyelectrolyte solutions, spanning biomedical, environmental, and pharmaceutical applications

Person of Ordinary Skill (PHOSITA) Profile

A skilled practitioner with advanced degrees in chemical engineering, materials science, or pharmaceutical sciences, possessing expertise in colloidal chemistry, polymer engineering, and drug delivery system design

Obviousness Rationale

A PHOSITA would recognize the source patent's colloidal particle formulation as a versatile platform technology with inherent adaptability across multiple application domains. The disclosed variations represent predictable extensions of the core technological framework by applying known targeting and delivery strategies to the established composite particle system. The fundamental technical principles of the original formulation can be readily translated to new contexts through routine optimization and design modifications.

Obvious Combinations & Variations

Source Patent Element
Engineered biodegradable particle core dispersed in bioadhesive polyelectrolyte solution
PTD Variation
Targeted cosmetic treatment delivery system focusing on skin pore penetration
Obviousness Reasoning
Predictable application of existing particle technology to dermatological delivery, utilizing known surface modification and targeting techniques common in cosmetic formulation
Source Patent Element
Composite colloidal particle formulation with controllable release characteristics
PTD Variation
Oral vaccine administration device with controlled gastrointestinal tract release
Obviousness Reasoning
Routine engineering adaptation of existing particle system to vaccine delivery, leveraging established principles of controlled pharmaceutical release mechanisms
Source Patent Element
Bioadhesive polyelectrolyte solution with engineered particle interactions
PTD Variation
Environmental pollutant detection system using particle-based sensing mechanism
Obviousness Reasoning
Obvious extension of particle system's inherent detection capabilities through standard sensor design principles and known chemical interaction strategies
Source Patent Element
Ethanol-based solvent processing method for particle formation
PTD Variation
Respiratory disease treatment using inhalable particle formulation
Obviousness Reasoning
Straightforward translation of particle production technique to pulmonary drug delivery, utilizing well-established pharmaceutical engineering approaches
35 U.S.C. § 103 Summary: Based on US Patent 11856948, the disclosed published technical disclosure demonstrates that the claimed variations in colloidal particle formulation applications would have been obvious to a person having ordinary skill in the art at the time of invention, as the core technological principles enable predictable adaptation across multiple technical domains through routine engineering modifications.

Original Patent Information

Patent NumberUS 11,856,948
TitleColloidal particle formulations with advanced functionality
Assignee(s)BENANOVA INC.